Characterisation of proguanylin expressing cells in the intestine – evidence for constitutive luminal secretion

Archive ouverte

Dye, Florent Serge | Larraufie, Pierre | Kay, Richard | Darwish, Tamana | Rievaj, Juraj | Goldspink, Deborah, A | Meek, Claire, L | Middleton, Stephen, J | Hardwick, Richard, H | Roberts, Geoffrey, P | Percival-Alwyn, Jennifer, L | Vaughan, Tris | Ferraro, Franco | Challis, Benjamin, G | O’rahilly, Stephen | Groves, Maria | Gribble, Fiona, M | Reimann, Frank

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract Guanylin, a peptide implicated in regulation of intestinal fluid secretion, is expressed in the mucosa, but the exact cellular origin remains controversial. In a new transgenic mouse model fluorescent reporter protein expression driven by the proguanylin promoter was observed throughout the small intestine and colon in goblet and Paneth(-like) cells and, except in duodenum, in mature enterocytes. In Ussing chamber experiments employing both human and mouse intestinal tissue, proguanylin was released predominantly in the luminal direction. Measurements of proguanylin expression and secretion in cell lines and organoids indicated that secretion is largely constitutive and requires ER to Golgi transport but was not acutely regulated by salt or other stimuli. Using a newly-developed proguanylin assay, we found plasma levels to be raised in humans after total gastrectomy or intestinal transplantation, but largely unresponsive to nutrient ingestion. By LC-MS/MS we identified processed forms in tissue and luminal extracts, but in plasma we only detected full-length proguanylin. Our transgenic approach provides information about the cellular origins of proguanylin, complementing previous immunohistochemical and in-situ hybridisation results. The identification of processed forms of proguanylin in the intestinal lumen but not in plasma supports the notion that the primary site of action is the gut itself.

Suggestions

Du même auteur

Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells

Archive ouverte | Ming, Yang | CCSD

International audience. Even though metformin is widely used to treat type2 diabetes, reducing glycaemia and body weight, the mechanisms of action are still elusive. Recent studies have identified the gastrointestin...

Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery

Archive ouverte | Larraufie, Pierre | CCSD

International audience

Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling

Archive ouverte | Roberts, Geoffrey, P | CCSD

International audience

Chargement des enrichissements...